Table 4.
Group | Patients, No. | Positive by Ag5, No. (%) | P Value |
---|---|---|---|
Active-transitional | |||
Total | 94 | 90 (95.7) | .03a |
CE1 | 7 | 7 (100.0) | NA |
CE2 | 9 | 9 (100) | .50 |
CE3a | 27 | 26 (96.3) | .22 |
CE3b | 51 | 48 (94.1) | .34 |
Inactive | |||
Total | 54 | 41 (75.9) | <.001a |
CE4 | 36 | 31 (86.1) | <.001a |
CE5 | 18 | 10 (55.6) | .008a |
Postsurgical | 25 | 19 (76.0) | .008a |
Healthy controls | 249 | 13 (5.2) | .21 |
Abbreviations: Ag5, antigen 5; AgB1, antigen B1; ELISA, enzyme-linked immunosorbent assay; NA, not applicable.
Statistically significant difference (McNemar test).